Display options
Share it on

Biomarkers. 2011 Dec;16(8):629-36. doi: 10.3109/1354750X.2011.608132. Epub 2011 Aug 29.

Potential clinical insights into microRNAs and their target genes in esophageal carcinoma.

Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals

Su Q Li, He M Wang, Xiu F Cao

Affiliations

  1. Department of Surgical Oncology, Affiliated Nanjing First Hospital of Nanjing Medical University and Oncology Center of Nanjing Medical University, Nanjing, Jiangsu Province, China.

PMID: 21870994 DOI: 10.3109/1354750X.2011.608132

Abstract

Esophageal carcinoma (EC) are characterized by dysregulation of microRNAs, which play an important roles as a posttranscriptional regulators in protein synthesis, and are involved in cellular processes, such as proliferation, apoptosis, and differentiation. Recently, altered miRNAs expression has been comprehensively studied in EC by high-throughput technology. Increased understanding of miRNAs target genes and their potential regulatory mechanisms have clarified the miRNAs activities and may provide exciting opportunities for cancer diagnosis and miRNA-based genetherapy. Here, we reviewed the most recently discovered miRNA target genes, with particular emphasis on the deciphering of their possible mechanisms and the potential roles in miRNAs-based tumour therapeutics.

Substances

MeSH terms

Publication Types